95%126%27.7%
Profitability Improvement
TECH achieved a 95% increase in operating income and a 126% rise in net income, primarily due to a 27.7% reduction in SG&A expenses.
Source: Source: 10-Q Income Statement, p.1
AI Takeaway
TECH's Q3 FY2026 results show a significant improvement in profitability despite a slight decline in revenue, driven by cost reductions and increased operational efficiency.
Revenue
$311.42M
-1.51% YoY
EPS (Basic)
$0.33
++135.71% YoY
Gross Margin
66.9%
-0.97% YoY
Operating Income
$75.5M
++95.04% YoY
Filed · Analysis updated · Source: SEC EDGAR 10-Q filing
TECH achieved a 95% increase in operating income and a 126% rise in net income, primarily due to a 27.7% reduction in SG&A expenses.
Source: Source: 10-Q Income Statement, p.1
Revenue decreased by 1.5% year-over-year, indicating challenges in maintaining sales growth.
Source: Source: 10-Q Income Statement, p.1
Cash and equivalents increased by 49.2%, enhancing liquidity and financial flexibility.
Source: Source: 10-Q Balance Sheet, p.1
The 1.5% year-over-year decline in revenue suggests potential challenges in market demand or competitive pressures.
Source: Source: 10-Q Income Statement, p.1
Unlock 2 more detailed risk analysis
Upgrade to unlockReported EPS of $0.53 versus the $0.55 analyst consensus — a -3.3% miss for Q3 FY2026.
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $311.42M | $316.18M | -1.51% |
Cost of Revenue | $103.13M | $101.63M | +1.48% |
Gross Profit | $208.29M | $214.56M | -2.92% |
Operating Income | $75.5M | $38.71M | +95.04% |
Net Income | $51.05M | $22.59M | +125.99% |
EPS (Basic) | $0.33 | $0.14 | +135.71% |
EPS (Diluted) | $0.32 | $0.14 | +128.57% |
SG&A Expense | $109.34M | $151.27M | -27.72% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.55B | $2.64B | -3.54% |
Current Assets | $688.05M | $627.24M | +9.69% |
Current Liabilities | $153.28M | $169.2M | -9.41% |
Stockholders' Equity | $2.09B | $2.02B | +3.33% |
Cash & Equivalents | $209.82M | $140.67M | +49.16% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash FlowYTD | $196.66M | $189.35M | +3.86% |
Investing Cash FlowYTD | $-11.13M | $-35.59M | +68.72% |
Financing Cash FlowYTD | $-135.91M | $-163.45M | +16.85% |
Share BuybacksYTD | $24,000 | $175.67M | -99.99% |
D&AYTD | $73.22M | $82.79M | -11.56% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 66.9% | 67.9% | -0.97% |
Operating Margin | 24.2% | 12.2% | +12.00% |
Net Margin | 16.4% | — | — |
ROE | 2.4% | — | — |
ROA | 2.0% | — | — |
Current Ratio | $4.489 | — | — |
Other companies in Life Sciences Tools & Services
TECH's Q3 FY2026 results showed a significant increase in net income and EPS, but specific earnings estimates are not provided in the filing.
Key takeaways include a 126% increase in net income, a 95% rise in operating income, and a 1.5% decline in revenue, highlighting improved profitability despite sales challenges.
Risks include a decline in revenue, potential challenges in maintaining cost reductions, and a decrease in total assets.
TECH's revenue decreased by 1.5% year-over-year to $311.4M, indicating challenges in market demand.
TECH's financial health is strong, with a 49.2% increase in cash and equivalents and a current ratio of 4.49, indicating robust liquidity.